All Reports Events Blogs Videos
Showing 12 results
  • Thematic Report
    May 04, 2026

    The global Clinical Research Organization (CRO) market is undergoing a transformation, shaped by rising clinical trial complexity, increasing regulatory requirements, and growing demand for faster, more efficient drug development. CROs continue to play a pivotal role…
  • Thematic Report
    March 26, 2026

    Pharmaceutical enterprises are reassessing their IT services sourcing strategies amid moderate growth, budget discipline, and rising innovation expectations. As provider consolidation intensifies, a small group of leading providers continues to capture a disproportionate share of enterprise…
  • Viewpoint
    April 28, 2026

    The global safety database market is at an inflection point, driven by increasing complexities in Pharmacovigilance (PV) operations, growing regulatory expectations, and rapid expansion of data sources such as real-world evidence, digital health tools, and patient-generated…
  • Provider Compendium
    March 26, 2026

    Healthcare enterprises are increasingly relying on specialist IT providers to address the growing complexities of healthcare transformation, regulatory compliance, and digital innovation. Payers and providers are under pressure to modernize core systems, improve interoperability, enable digital…
  • Tech Launch Perspective
    May 18, 2026

    The Data and Analytics (D&A) market continues to evolve rapidly as enterprises modernize fragmented data estates, improve governance, and prepare their data foundations for AI and agentic workloads. Organizations are prioritizing unified, interoperable, and real-time data…
  • Tech Launch Perspective
    April 16, 2026

    Ivalua’s product announcements at Ivalua NOW 2026 reflect a strategic shift from embedded AI functionality toward a more extensible Source-to-Pay (S2P) platform enabled with agentic capabilities. With IVA serving as the front-end experience and IVA Studio…
  • Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • Discovery
    March 19, 2026

    Discoveries focus on specific science and technology innovations that address today’s critical business issues and challenges. These brief yet detailed profiles highlight innovations across the world's leading companies, start-ups, universities, institutes, and the entire R&D ecosystem…
  • NEW
    Voice of the Customer
    May 22, 2026

    Enterprises are redefining their Master Data Management (MDM) strategies as data reliability, governance, and AI readiness become central to enterprise transformation. As organizations modernize their data architecture and scale AI, generative AI, analytics, and automation initiatives,…
  • Technology Awareness Deep Dive
    April 27, 2026

    Over the past decade, Cell and Gene Therapies (CGTs) have evolved significantly in terms of safety and efficacy, demonstrating their ability to rectify, replace, or reprogram diseased biology at its source. However, despite growing clinical validation…
  • Tech Provider Spotlight
    March 19, 2026

    Life sciences commercial engagement is undergoing a fundamental transformation as enterprises move from siloed, channel-centric models to coordinated, customer-centric omnichannel strategies. Increasing Healthcare Professionals (HCP) access constraints, evolving customer expectations, proliferation of digital channels, and mounting…
  • Innovation Watch
    March 03, 2026

    As enterprises accelerate AI adoption, managing and retrieving high-dimensional data has become an essential capability. Organizations are increasingly complementing and augmenting traditional databases with vector data platforms purpose-built to store and query embeddings generated through AI…